Diagnosis, Management, and Outcome of Antituberculous Drug-Induced Liver Injury in a Low-Resource Setting: A Case Report. [PDF]
Case Rep Infect DisAlomatu S +5 more
europepmc +1 more source
A 31-Year-Old Woman With Liver Cirrhosis Due to Wilson Disease and the Double Impact of Active Tuberculosis and Anti-Tuberculosis Therapy Resulting in Acute Liver Injury. [PDF]
Am J Case RepTrifonov P +4 more
europepmc +1 more source
Case Report: Nephrotic syndrome with minimal change disease during anti-tuberculosis treatment and tiopronin use. [PDF]
Front Med (Lausanne)Liao H, Yan F, Liu X.
europepmc +1 more source
From mutation detection to treatment decisions: CRISPR-enabled diagnostics for drug-resistant tuberculosis. [PDF]
Front Bioeng BiotechnolYi W +6 more
europepmc +1 more source
Isoniazid monotherapy for tuberculosis prevention during pregnancy and adverse outcomes in women living with HIV in Uganda: A propensity score-weighted analysis of routine care data. [PDF]
PLOS Glob Public HealthMusaazi J +7 more
europepmc +1 more source
Genetic Landscape of NAT2 in the Moroccan Population: Implications for Isoniazid Pharmacogenetics in Tuberculosis. [PDF]
Clin Transl SciBenyahya N +6 more
europepmc +1 more source
Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole-Based Hydrazide Derivatives as Potential Anti-Tuberculosis Agents. [PDF]
Chem Biol Drug DesSharma V, Sharma A, Poria R, Kumar P.
europepmc +1 more source
Rapid Eukaryotic Impedimetric Biosensing of Naproxen and Isoniazid: A Proof-of-Concept for Acute Toxicity Monitoring. [PDF]
Biosensors (Basel)Štukovnik Z, Perko N, Bren U.
europepmc +1 more source
Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning-based prediction in <i>Mycobacterium tuberculosis</i> clinical isolates. [PDF]
Front MicrobiolHao Z +5 more
europepmc +1 more source